RhumbLine Advisers’s Radius Health, Inc. RDUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-56,123
| Closed | -$582K | – | 3095 |
|
|
2022
Q2 | $582K | Buy |
56,123
+5,764
| +11% | +$42.9K | ﹤0.01% | 2412 |
|
|
2022
Q1 | $445K | Sell |
50,359
-2,385
| -5% | -$18.1K | ﹤0.01% | 2476 |
|
|
2021
Q4 | $365K | Sell |
52,744
-1,295
| -2% | -$19K | ﹤0.01% | 2636 |
|
|
2021
Q3 | $671K | Buy |
54,039
+2,047
| +4% | +$29.5K | ﹤0.01% | 2419 |
|
|
2021
Q2 | $948K | Sell |
51,992
-4,028
| -7% | -$80.1K | ﹤0.01% | 2269 |
|
|
2021
Q1 | $1.17M | Sell |
56,020
-7,518
| -12% | -$158K | ﹤0.01% | 2134 |
|
|
2020
Q4 | $1.14M | Buy |
63,538
+2,683
| +4% | +$40.3K | ﹤0.01% | 2082 |
|
|
2020
Q3 | $690K | Sell |
60,855
-14,086
| -19% | -$174K | ﹤0.01% | 2146 |
|
|
2020
Q2 | $1.02M | Buy |
74,941
+1,041
| +1% | +$14.3K | ﹤0.01% | 2035 |
|
|
2020
Q1 | $961K | Buy |
73,900
+1,564
| +2% | +$27.9K | ﹤0.01% | 1894 |
|
|
2019
Q4 | $1.46M | Buy |
72,336
+4,618
| +7% | +$112K | ﹤0.01% | 1918 |
|
|
2019
Q3 | $1.74M | Buy |
67,718
+846
| +1% | +$20.7K | ﹤0.01% | 1815 |
|
|
2019
Q2 | $1.63M | Buy |
66,872
+4,044
| +6% | +$88.4K | ﹤0.01% | 1854 |
|
|
2019
Q1 | $1.25M | Buy |
62,828
+889
| +1% | +$16.2K | ﹤0.01% | 1932 |
|
|
2018
Q4 | $1.02M | Buy |
61,939
+26,702
| +76% | +$450K | ﹤0.01% | 1999 |
|
|
2018
Q3 | $627K | Sell |
35,237
-2,475
| -7% | -$56K | ﹤0.01% | 2189 |
|
|
2018
Q2 | $1.11M | Buy |
37,712
+1,719
| +5% | +$54.3K | ﹤0.01% | 1961 |
|
|
2018
Q1 | $1.29M | Sell |
35,993
-65
| -0.2% | -$2.35K | ﹤0.01% | 1827 |
|
|
2017
Q4 | $1.15M | Sell |
36,058
-9,977
| -22% | -$313K | ﹤0.01% | 1887 |
|
|
2017
Q3 | $1.77M | Buy |
46,035
+3,555
| +8% | +$140K | ﹤0.01% | 1685 |
|
|
2017
Q2 | $1.92M | Buy |
42,480
+3,740
| +10% | +$143K | ﹤0.01% | 1604 |
|
|
2017
Q1 | $1.5M | Buy |
38,740
+1,512
| +4% | +$63.4K | ﹤0.01% | 1715 |
|
|
2016
Q4 | $1.42M | Buy |
37,228
+2,116
| +6% | +$101K | ﹤0.01% | 1644 |
|
|
2016
Q3 | $1.9M | Buy |
35,112
+2,694
| +8% | +$137K | 0.01% | 1434 |
|
|
2016
Q2 | $1.19M | Buy |
32,418
+342
| +1% | +$12.1K | ﹤0.01% | 1674 |
|
|
2016
Q1 | $1.01M | Buy |
32,076
+405
| +1% | +$14K | ﹤0.01% | 1795 |
|
|
2015
Q4 | $1.95M | Buy |
31,671
+3,585
| +13% | +$226K | 0.01% | 1371 |
|
|
2015
Q3 | $1.95M | Buy |
28,086
+3,391
| +14% | +$236K | 0.01% | 1337 |
|
|
2015
Q2 | $1.67M | Buy |
24,695
+17,670
| +252% | +$823K | 0.01% | 1529 |
|
|
2015
Q1 | $289K | Buy |
+7,025
| New | +$316K | ﹤0.01% | 2640 |
|
Other funds holding RDUS
RhumbLine Advisers's RDUS Position: Q3 2022 in Review
RhumbLine Advisers sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 56,123 shares — an estimated $582K sold.
RhumbLine Advisers first reported a position in RDUS in Q1 2015 and held it in 30 quarters. The position peaked at $1.95M in Q4 2015. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.
- RhumbLine Advisers reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
- RhumbLine Advisers sold 56,123 Radius Health, Inc. shares in Q3 2022, an estimated $582K.
- RhumbLine Advisers first reported a position in Radius Health, Inc. in Q1 2015 and held it in 30 quarters.
- RhumbLine Advisers's Radius Health, Inc. position peaked at $1.95M in Q4 2015.
- 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.
Based on RhumbLine Advisers's 13F filing for Q3 2022, filed 10 Nov 2022.